These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19212684)
1. The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma. Do SI; Jung WW; Kim HS; Park YK Int J Oncol; 2009 Mar; 34(3):797-803. PubMed ID: 19212684 [TBL] [Abstract][Full Text] [Related]
2. Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma. Hughes DP; Thomas DG; Giordano TJ; Baker LH; McDonagh KT Cancer Res; 2004 Mar; 64(6):2047-53. PubMed ID: 15026342 [TBL] [Abstract][Full Text] [Related]
3. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985 [TBL] [Abstract][Full Text] [Related]
4. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors. Dobashi Y; Suzuki S; Sugawara H; Ooi A Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509 [TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304 [TBL] [Abstract][Full Text] [Related]
6. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251 [TBL] [Abstract][Full Text] [Related]
7. Characterization of STAT3 activation and expression in canine and human osteosarcoma. Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568 [TBL] [Abstract][Full Text] [Related]
8. Survivin expression levels as independent predictors of survival for osteosarcoma patients. Osaka E; Suzuki T; Osaka S; Yoshida Y; Sugita H; Asami S; Tabata K; Sugitani M; Nemoto N; Ryu J J Orthop Res; 2007 Jan; 25(1):116-21. PubMed ID: 17034065 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma. Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860 [TBL] [Abstract][Full Text] [Related]
10. MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Wang Q; Cai J; Wang J; Xiong C; Zhao J Tumour Biol; 2014 Dec; 35(12):12743-8. PubMed ID: 25227664 [TBL] [Abstract][Full Text] [Related]
12. Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations. Okamoto K; Okamoto I; Okamoto W; Tanaka K; Takezawa K; Kuwata K; Yamaguchi H; Nishio K; Nakagawa K Cancer Res; 2010 Dec; 70(24):10402-10. PubMed ID: 21159653 [TBL] [Abstract][Full Text] [Related]
13. Increased mRNA expression of epidermal growth factor receptor, human epidermal receptor, and survivin in human gastric cancer after the surgical stress of laparotomy versus carbon dioxide pneumoperitoneum in a murine model. Amin AT; Shiraishi N; Ninomiya S; Tajima M; Inomata M; Kitano S Surg Endosc; 2010 Jun; 24(6):1427-33. PubMed ID: 20041268 [TBL] [Abstract][Full Text] [Related]
14. EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance. Sevelda F; Mayr L; Kubista B; Lötsch D; van Schoonhoven S; Windhager R; Pirker C; Micksche M; Berger W J Exp Clin Cancer Res; 2015 Nov; 34():134. PubMed ID: 26526352 [TBL] [Abstract][Full Text] [Related]
15. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Zhang S; Wang Y; Chen S; Li J Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212 [TBL] [Abstract][Full Text] [Related]
16. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway. Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070 [TBL] [Abstract][Full Text] [Related]
17. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Yang R; Piperdi S; Gorlick R Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278 [TBL] [Abstract][Full Text] [Related]
18. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer. de Graeff P; Crijns AP; Ten Hoor KA; Klip HG; Hollema H; Oien K; Bartlett JM; Wisman GB; de Bock GH; de Vries EG; de Jong S; van der Zee AG Br J Cancer; 2008 Jul; 99(2):341-9. PubMed ID: 18628764 [TBL] [Abstract][Full Text] [Related]
19. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Chun KS; Langenbach R Mol Carcinog; 2011 Jun; 50(6):439-48. PubMed ID: 21268125 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]